WHO/UNICEF Technical Briefing Seminar, Geneva, Nov 2009

[Guest guest]

Copied as fair use from E-drug.

Desirous must apply. It is agreat learning opportunity.

I have been sponsored by WHO for two TBS at WHO HQ Geneva and one advance TBS at

Delhi.

Vijay

-------------------------------------------------------------------

E-DRUG: WHO/UNICEF Technical Briefing Seminar, Geneva, November 2009

Dear E-Druggers,

WHO/UNICEF Technical Briefing Seminar, Geneva, 16th November to 20th

November 2009

Herewith the first announcement of the annual Technical Briefing

Seminar, hosted by the WHO Department of Essential Medicines and

Pharmaceutical Policies (WHO/EMP). The web site for the announcement and

links to previous seminars are at:

http://www.who.int/medicines/technical_briefing/tbs/en/ .

The seminar is always oversubscribed, so please get your application in

on time. Note that Switzerland became a Schengen country in December

2008.

The closing date for submission of applications is 25 September 2009.

This technical briefing seminar is different from the more specialized

Technical Briefing Seminars, for example on Quality Assurance and

Safety, Blood Products, Biologicals ( 21st to 25th September 2009 ), and

Medicines Pricing ( to be held early in 2010 ). This year's seminar will

be facilitated by Dr Helene Moller and Dr Laing, WHO/EMP, with

input from partners and regional and country programme officers and

advisers. The draft agenda is on the website. A more specific agenda

will be made available shortly. Further details are provided below :

See Seminar Overview.

Participation in the seminar is free of charge but participants will

have to arrange for and finance their own travel, board and lodging.

Applications are to be submitted electronically by completing the form

on the website

http://www.who.int/medicines/technical_briefing/formulaire/en/index.html.

For further information, please contact Mrs Joanna McMahon or Dr Helene

Moller, WHO/EMP/MAR, 1211 Geneva, fax 41-22-7914167, or

e-mail

mcmahonj@...

mollerh@...

on behalf of

Dr H.V. Hogerzeil

Director, Department of Essential Medicines and Pharmaceutical Policies

World Health Organization, 1211 Geneva 27

Tel: 41.22.791.3528, Fax: 41.22.791.4730

Tel: 41.22.791.1458, Fax: 41.22.791.4167

___________________________________________________________________

SEMINAR OVERVIEW

WHO/UNICEF Technical Briefing Seminar on Essential Medicines Policies

Location: WHO/Headquarters, Geneva

Dates: 16-20 November 2009

A one-week Technical Briefing Seminar will be organized by the

Department of Essential Medicines and Pharmaceutical Policies (EMP), in

collaboration with UNICEF Supply Division, Copenhagen

Similar briefing seminars have been held annually since 1998.

Target audience

Priority is given to the following categories: technical advisers and

field staff of WHO, UNICEF and of other UN and bilateral agencies,

governmental and nongovernmental organizations, active in pharmaceutical

and health sector reform programmes in developing and transitional

countries and medicines experts working in the public sector, academic

institutions, consulting and civil society organizations.

Seminar objectives

By the end of the programme participants will:

1. have a general understanding of the most common problems in the

pharmaceutical sector in developing and transitional countries; and will

have shared experiences in addressing these challenges;

2. have a general understanding of how WHO and the UNICEF Supply

Division support developing and transitional countries in strengthening

the pharmaceutical sector;

3. appreciate the importance of National Drug Policies as the best

approach to make essential medicines of good quality available to all

who need them, and ensure the rational use of medicines;

4. be aware of ways to strengthen collaboration with WHO and other

organizations supporting the pharmaceutical sector in developing and

transitional countries;

5. understand the impact of international agreements on pharmaceuticals;

6. be aware of current issues such as pharmacovigilance, pricing issues,

traditional medicines and counterfeit medicines.

Seminar outline

Sessions will be devoted to developing National Drug Policies, Selection

of essential medicines, access to essential drugs including

affordability and financing, the impact of globalization and trade

agreements, drug regulation and quality assurance, drug procurement and

supply systems, pharmacovigilance and drug safety, promoting rational

medicine use, and coordination between international agencies. The

programme includes updates on the Global Fund, UNITAID, the Affordable

Medicines for Malaria programme, the UN pre-qualification project, the

outcomes of the Meetings of the various Expert Committees hosted by the

department. Participants will have access to all Essential

Medicines-related information resources.

Presenters and facilitators

Sessions will be led and facilitated by senior staff members of the

Department of Essential Medicines and Pharmaceutical Policies. Other

sessions are supported by colleagues from other agencies and departments

in WHO involved in pharmaceutical matters. One afternoon is available

for individual appointments with WHO staff.

Please note that every year we receive more applications than places

available in the seminar. There is therefore a rigorous selection

procedure in place, with strict adherence to the cut-off date for

applications to allow sufficient time for selected participants to

complete their travel arrangements.